Q9UMS4 (PRP19_HUMAN) Homo sapiens (Human)

Pre-mRNA-processing factor 19 UniProtKBInterProSTRINGInteractive Modelling

504 aa; Sequence (Fasta) ; 23 identical sequences

Available Structures

21 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
The Cryo-EM Structure of Human Catalytic Step I Spliceosome (C complex) at 4.1 angstrom resolution Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13427; Q13573; Q15029; Q6P2Q9; Q92620; Q96A72; Q96BP3; Q96DI7; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9NXE8; Q9P013; Q9ULR0; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y5S9;
3-504
100IHP;GTP;MG;ADP;ZN;ATP;
Structure of a late-stage activated spliceosome (BAqr) arrested with a dominant-negative Aquarius m… Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UNP9; Q9UQ35; Q9Y3C6;
2-138
100.012×ZN;IHP;GTP;MG;
Human post-catalytic P complex spliceosome Heteromer
O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6IQ49; Q6P2Q9; Q8N5F7; Q8WUQ7; Q96A72; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9;
2-138
100.0MG;K;ATP;GTP;ZN;IHP;
human Bact spliceosome core structure Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
3-137
10011×ZN;MG;IHP;GTP;ADP;
Cryo-EM structure of a human spliceosome activated for step 2 of splicing (C* complex) Heteromer
O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6;
3-137
100
Human C Complex Spliceosome - Medium-resolution PERIPHERY Heteromer
O60306; O60508; O75643; O75934; O95926; P08579; P09661; P14678; P38919; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14331; Q6P2Q9; Q92620; Q96BP3; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9NW82; Q9ULR0; Q9UNP9; Q9UQ35; Q9Y5S9;
3-137
100
Integrative Structure of the human intron lariat Spliceosome (ILS'') Heteromer
O43143; O43660; O60306; O60508; O75934; O95926; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q15029; Q2TBE0; Q69YN2; Q6IQ49; Q6P2Q9; Q8WUD4; Q96DF8; Q96DI7; Q99459; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UBB9; Q9ULR0; Q9Y3C6; Q9Y5B6;
1-134
100GTP;ZN;IHP;
The cryo-EM structure of human Bact-III complex Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6;
3-134
100IHP;GTP;MG;ZN;
The cryo-EM structure of human pre-C*-II complex Heteromer
O15234; O43660; O60306; O60508; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q8WUQ7; Q96DI7; Q99459; Q9BZJ0; Q9GZU8; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9;
3-134
100IHP;GTP;MG;ZN;ATP;
The cryo-EM structure of human post-Bact complex Heteromer
O43660; O60231; O60306; O60508; O75533; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13435; Q13573; Q15029; Q15393; Q15427; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6;
3-134
100IHP;GTP;MG;ZN;
The cryo-EM structure of human C* complex Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q8N5F7; Q8WUQ7; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y421; Q9Y5S9;
3-134
100IHP;GTP;MG;ZN;ATP;
The cryo-EM structure of human Bact-IV complex Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6;
3-134
100IHP;GTP;MG;ZN;
The cryo-EM structure of human C complex Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14331; Q15029; Q6P2Q9; Q86X95; Q92620; Q96BP3; Q96DI7; Q99459; Q9BW85; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9NW82; Q9NXE8; Q9P013; Q9ULR0; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y5S9;
3-134
100IHP;GTP;MG;ZN;
Cryo-EM structure of a human intron lariat spliceosome after Prp43 loaded (ILS2 complex) at 2.9 ang… Heteromer
O43143; O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q15029; Q2TBE0; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y3C6;
3-134
100IHP;GTP;MG;ZN;
Cryo-EM structure of a human intron lariat spliceosome prior to Prp43 loaded (ILS1 complex) at 2.9 … Heteromer
O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q15029; Q2TBE0; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y3C6;
3-134
100IHP;GTP;MG;ZN;
Cryo-EM structure of a human post-catalytic spliceosome (P complex) at 3.0 angstrom Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96A72; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y5S9;
3-134
100IHP;GTP;MG;ZN;ATP;
The cryo-EM structure of human pre-C*-I complex Heteromer
O15234; O43660; O60306; O60508; O75934; O95926; P08579; P09661; P14678; P38919; P41223; P61326; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96DI7; Q99459; Q9BZJ0; Q9GZU8; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6; Q9Y5S9;
3-134
100IHP;GTP;MG;ZN;ATP;
Cryo-EM structure of the human spliceosome just prior to exon ligation at 3.6 angstrom Heteromer
O15234; O43660; O60306; O60508; O75643; O75934; O95391; O95926; P08579; P09661; P14678; P38919; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13573; Q14562; Q15029; Q6P2Q9; Q96A72; Q96DI7; Q99459; Q9BZJ0; Q9H875; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UQ35; Q9Y3C6; Q9Y5S9;
3-134
100IHP;GTP; 11×MG;ADP;ZN;ATP;
cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom. Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
3-134
100IHP;GTP;MG; 13×ZN;
Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom Heteromer
O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
3-134
100IHP;ALA;GTP;MG; 10×ZN;
Crystal structure of PRPF19 WD40 repeatsmonomer195-504
100NA; 14×UNX;

5 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2ymu.1.Amonomer0.71221-503
26.64
7b9v.1.kmonomer0.583-131
23.33
5mqf.1.Hmonomer0.533-137
100.00
7b9v.1.mmonomer0.523-496
23.33
6bk8.1.hmonomer0.523-496
23.33